Literature DB >> 10383824

Paul Ehrlich's passion: the origins of his receptor immunology.

A M Silverstein1.   

Abstract

In 1897, Paul Ehrlich published a selection theory of antibody formation that anticipated the theories of Jerne and Burnet by some 60 years. Ehrlich introduced into immunology the concept of the interaction of physiologically active substances with specific receptors, an idea that still dominates modern immunological thought. In this paper, we point out how Ehrlich's concept matured over 20 years, while it governed his studies in histological staining, in cell physiology, in hematology, and finally in his major contributions in experimental immunology. Copyright 1999 Academic Press.

Mesh:

Substances:

Year:  1999        PMID: 10383824     DOI: 10.1006/cimm.1999.1505

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  6 in total

Review 1.  Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance.

Authors:  Ralph Marvin Steinman; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

Review 2.  Cato Guldberg and Peter Waage, the history of the Law of Mass Action, and its relevance to clinical pharmacology.

Authors:  Robin E Ferner; Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2015-10-22       Impact factor: 4.335

Review 3.  Antibody-Drug Conjugates in Uro-Oncology.

Authors:  Dawid Sigorski; Paweł Różanowski; Ewa Iżycka-Świeszewska; Katarzyna Wiktorska
Journal:  Target Oncol       Date:  2022-05-14       Impact factor: 4.864

Review 4.  Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications.

Authors:  Emma M Hays; Wei Duan; Sarah Shigdar
Journal:  Int J Mol Sci       Date:  2017-11-30       Impact factor: 5.923

5.  Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade.

Authors:  Luciano Polonelli; Concetta Beninati; Giuseppe Teti; Franco Felici; Tecla Ciociola; Laura Giovati; Martina Sperindè; Carla Lo Passo; Ida Pernice; Maria Domina; Milena Arigò; Salvatore Papasergi; Giuseppe Mancuso; Stefania Conti; Walter Magliani
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

Review 6.  Therapeutic applications of monoclonal antibodies.

Authors:  Mitchell Berger; Vidya Shankar; Abbas Vafai
Journal:  Am J Med Sci       Date:  2002-07       Impact factor: 2.378

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.